‘Major Milestone:’ FDA Gives CLIA Waiver To Chlamydia, Gonorrhea Test

The 30-minute Binx IO test will now be available to more than 220,000 point-of-care facilities that have a CLIA waiver. Health experts say it will help treat patients faster and stymie the spread of STIs.

The Binx IO test has received CLIA Waiver to be used at POC locations to diagnose chlamydia and gonorrhea
The Binx IO test has received CLIA Waiver to be used at POC locations to diagnose chlamydia and gonorrhea • Source: Binx

More from Regulation

More from Policy & Regulation